Article
Methionine-dependence phenotype in the de novo pathway in BRCA1 and BRCA2 mutation carriers with and without breast cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Oct 2008
Beetstra Sasja, Suthers Graeme, Dhillon Varinderpal, Salisbury Carolyn, Turner Julie, Altree Meryl, McKinnon Ross, Fenech Michael
Abstract excerpt
Methionine-dependence phenotype (MDP) refers to the reduced ability of cells to proliferate when methionine is restricted and/or replaced by its immediate precursor homocysteine. MDP is a characteristic of human tumors in vivo, human tumor cell lines, and normal somatic tissue in some individuals. It was hypothesized that MDP is a risk factor for developing breast cancer in BRCA (BRCA1 and BRCA2) germline...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
